--- title: "邁威生物-U (688062.SH) — 財務報表" type: "Symbol" locale: "zh-HK" url: "https://longbridge.com/zh-HK/quote/688062.SH/norm.md" symbol: "688062.SH" name: "邁威生物-U" parent: "https://longbridge.com/zh-HK/quote/688062.SH.md" datetime: "2026-03-09T20:03:57.077Z" locales: - [en](https://longbridge.com/en/quote/688062.SH/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/688062.SH/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/688062.SH/norm.md) --- > 支持的語言: [English](https://longbridge.com/en/quote/688062.SH/norm.md) | [简体中文](https://longbridge.com/zh-CN/quote/688062.SH/norm.md) # 邁威生物-U (688062.SH) — 財務報表 ## 損益表 (CNY) | 指標 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | 每股收益 | -0.9274 | -0.1169 | -0.6500 | -0.7300 | -0.8677 | | ROE | -195.78% | -23.48% | -99.12% | -82.00% | -80.28% | | 營業收入 | 96.68M | 464.67M | 56.38M | 44.79M | 58.69M | | 凈利潤 | -372.52M | -46.34M | -259.59M | -291.73M | -349.83M | | 營業利潤 | -446.65M | 32.63M | -272.57M | -269.57M | -348.70M | | 毛利率 | 140.11% | 97.95% | 65.83% | 77.73% | 59.38% | | 凈利率 | -385.32% | -9.97% | -460.46% | -651.35% | -596.11% | | 利潤含金量 | - | -47.22% | -149.20% | - | - | ## 資產負債表 (CNY) | 指標 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | 資產與負債 | - | 4.53B | 4.47B | 4.19B | 4.28B | | 權益乘數 | - | 4.79 | 4.45 | 3.32 | 2.75 | | 每股凈資產 | 1.91 | 1.91 | 2.05 | 3.20 | 3.93 | | 資產周轉率 | - | 0.1384 | 0.0411 | 0.0401 | 0.0458 | | 現金及短投 | 1.48B | 1.48B | 1.39B | 1.13B | 1.23B | | 存貨與應收 | - | 198.56M | 210.84M | 220.22M | 211.68M | | 長期投資 | - | 2.00B | 1.99B | 2.02B | 2.05B | | 凈債務 | 1.07B | 1.07B | 885.06M | 1.25B | 983.91M | ## 現金流量表 (CNY) | 指標 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | 經營現金流 | - | -69.11M | 182.69M | -216.62M | -288.22M | | 投資現金流 | - | -100.84M | -45.25M | -54.98M | -88.38M | | 融資現金流 | - | 221.88M | 114.23M | 181.13M | 4.56M | | 自由現金流 | - | -328.26M | 350.08M | -261.89M | -106.58M | | 現金流充裕率 | - | -25.94% | 51.50% | -36.60% | -19.39% | | 舉債與償債 | - | 418.70M | 215.30M | 651.84M | 1.37B | | 資本支出 | - | -44.06M | -51.77M | -35.44M | -103.61M |